Clinical Trial Update: Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update for a tetravalent dengue vaccine administered with Adacel either concurrently or sequentially in healthy subjects; study terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))
• Tetravalent dengue vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Status: TERMINATED | Results posted: 2020-08-27